Photo: Adrien Olichon / Unsplash
Member of Sarcolaenaceae - one of five plant families found exclusively in Madagascar. Every compound isolated is structurally novel by definition. 80+ million years of isolated evolution.
Photo: Adrien Olichon / Unsplash
Sarcolaena multiflora is a member of Sarcolaenaceae - one of five plant families found exclusively in Madagascar, with no representatives anywhere else on Earth. This is not subspecies-level endemism or genus-level rarity: it is entire-family endemism, representing over 80 million years of isolated evolution with no biosynthetic exchange with any continental flora.
The consequence for pharmaceutical discovery is categorical: every secondary metabolite isolated from a member of Sarcolaenaceae is structurally novel by definition. There is no continental relative producing analogous compounds. There is no comparative database entry. There is no existing IP covering the compound class. The chemistry is irreducibly original.
Novel by definition: Most natural product discovery programmes must demonstrate structural novelty compound by compound. For Sarcolaenaceae, novelty is guaranteed at the family level - the entire chemistry of this evolutionary lineage is absent from every compound library on Earth. This is a unique property of Madagascar's five endemic plant families.
The Tsingy de Bemaraha and associated limestone karst formations impose extreme phosphorus starvation on their plant communities. Pure calcium carbonate substrate, virtually devoid of nitrogen and phosphorus, forces metabolic flux into phenylpropanoid, flavonoid, and alkaloid pathways that are disproportionately rich relative to biomass. Sarcolaena species persisting in karst conditions have been under this selective pressure for millions of years, producing flavonoid and xanthone chemistry of particular interest for anti-inflammatory and antioxidant screening programmes.